Evidence map›Paper›PMID 29466436›Full record

ArticlePloS one2018

Loss of HCN2 leads to delayed gastrointestinal motility and reduced energy intake in mice.

Daniel W Fisher, Phillip Luu, Neha Agarwal, Jonathan E Kurz, Dane M Chetkovich

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Mutants of the Zebrafish KInternational journal of molecular sciences · 2021
    Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Daniel W FisherDavee Department of Neurology and Clinical Neurosciences, Northwestern University Feinberg School of Medicine, Chicago, IL, United States of America.ORCID 0000-0003-3271-8327
Phillip LuuDavee Department of Neurology and Clinical Neurosciences, Northwestern University Feinberg School of Medicine, Chicago, IL, United States of America.
Neha AgarwalDavee Department of Neurology and Clinical Neurosciences, Northwestern University Feinberg School of Medicine, Chicago, IL, United States of America.
Jonathan E KurzDepartment of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL, United States of America.
Dane M ChetkovichDavee Department of Neurology and Clinical Neurosciences, Northwestern University Feinberg School of Medicine, Chicago, IL, United States of America.
Northwestern University · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM008152 · NIGMS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI ARDEHALI, HOSSEIN · 1987 to 2021
$24.0M
Medical Scientist Training ProgramT32GM144295 · NIGMS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI ALAN R HAUSER · 2022 to 2026
$9.1M
HCN Channel Trafficking in EpilepsyR01NS059934 · NINDS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI CHETKOVICH, DANE M · 2008 to 2017
$3.1M
Discovery of novel small molecule antidepressantsR01MH106511 · NIMH · VANDERBILT UNIVERSITY MEDICAL CENTER · PI CHETKOVICH, DANE M, SCHILTZ, GARY E · 2016 to 2018
$1.1M
Characterizing antidepressant-like effects of a novel peptide HCN channel inhibitorR21MH113262 · NIMH · VANDERBILT UNIVERSITY MEDICAL CENTER · PI CHETKOVICH, DANE M · 2017 to 2018
$430k
Evaluation of antidepressant-like effects of hippocampal HCN channel modulationR21MH104471 · NIMH · NORTHWESTERN UNIVERSITY AT CHICAGO · PI CHETKOVICH, DANE M · 2014 to 2015
$410k
Role of HCN Channels in Major Depressive Disorder Etiology and TreatmentF30MH109249 · NIMH · NORTHWESTERN UNIVERSITY AT CHICAGO · PI FISHER, DANIEL W. · 2015 to 2018
$142k
NIGMS NIH HHS T32 GM008152NIGMS NIH HHS T32 GM144295NIH HHS F30MH109249NIH HHS R01MH106511NIH HHS R21MH104471NIMH NIH HHS F30 MH109249NIMH NIH HHS R01 MH106511NIMH NIH HHS R21 MH104471NIMH NIH HHS R21 MH113262NINDS NIH HHS R01 NS059934
6 · The paper itself

Abstract

Hyperpolarization-activated Cyclic Nucleotide-gated (HCN) channels are important regulators of excitability in neural, cardiac, and other pacemaking cells, which are often altered in disease. In mice, loss of HCN2 leads to cardiac dysrhythmias, persistent spike-wave discharges similar to those seen in absence epilepsy, ataxia, tremor, reduced neuropathic and inflammatory pain, antidepressant-like behavior, infertility, and severely restricted growth. While many of these phenotypes have tissue-specific mechanisms, the cause of restricted growth in HCN2 knockout animals remains unknown. Here, we characterize a novel, 3kb insertion mutation of Hcn2 in the Tremor and Reduced Lifespan 2 (TRLS/2J) mouse that leads to complete loss of HCN2 protein, and we show that this mutation causes many phenotypes similar to other mice lacking HCN2 expression. We then demonstrate that while TRLS/2J mice have low blood glucose levels and impaired growth, dysfunction in hormonal secretion from the pancreas, pituitary, and thyroid are unlikely to lead to this phenotype. Instead, we find that homozygous TRLS/2J mice have abnormal gastrointestinal function that is characterized by less food consumption and delayed gastrointestinal transit as compared to wildtype mice. In summary, a novel mutation in HCN2 likely leads to impaired GI motility, causing the severe growth restriction seen in mice with mutations that eliminate HCN2 expression.

Indexed as

AnimalsBlood GlucoseEnergy IntakeFemaleGastrointestinal MotilityHyperpolarization-Activated Cyclic Nucleotide-Gated ChannelsMaleMiceMice, Inbred C57BLMice, KnockoutMutagenesis, InsertionalSequence Analysis, DNABlood GlucoseHyperpolarization-Activated Cyclic Nucleotide-Gated Channels

Identifiers

PMID29466436
PMCPMC5821371
OpenAlexW2794407562

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.